Combination treatment for severe aplastic anemia improves responses by preventing cytotoxic T-lymphocyte–mediated attack on hematopoietic stem cells and boosting stem cell function through thrombopoietin growth factor signaling. ATG/CsA, anti-thymocyte globulin/cyclosporine.